Literature DB >> 33462293

Influence of energy deficiency on the subcellular processes of Substantia Nigra Pars Compacta cell for understanding Parkinsonian neurodegeneration.

Vignayanandam Ravindernath Muddapu1, V Srinivasa Chakravarthy2.   

Abstract

Parkinson's disease (PD) is the second most prominent neurodegenerative disease around the world. Although it is known that PD is caused by the loss of dopaminergic cells in substantia nigra pars compacta (SNc), the decisive cause of this inexorable cell loss is not clearly elucidated. We hypothesize that "Energy deficiency at a sub-cellular/cellular/systems level can be a common underlying cause for SNc cell loss in PD." Here, we propose a comprehensive computational model of SNc cell, which helps us to understand the pathophysiology of neurodegeneration at the subcellular level in PD. The aim of the study is to see how deficits in the supply of energy substrates (glucose and oxygen) lead to a deficit in adenosine triphosphate (ATP). The study also aims to show that deficits in ATP are the common factor underlying the molecular-level pathological changes, including alpha-synuclein aggregation, reactive oxygen species formation, calcium elevation, and dopamine dysfunction. The model suggests that hypoglycemia plays a more crucial role in leading to ATP deficits than hypoxia. We believe that the proposed model provides an integrated modeling framework to understand the neurodegenerative processes underlying PD.

Entities:  

Year:  2021        PMID: 33462293     DOI: 10.1038/s41598-021-81185-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  155 in total

Review 1.  200 Years of Parkinson's disease: what have we learnt from James Parkinson?

Authors:  Claire McDonald; Gavin Gordon; Annette Hand; Richard W Walker; James M Fisher
Journal:  Age Ageing       Date:  2018-03-01       Impact factor: 10.668

2.  A single compartment model of pacemaking in dissasociated substantia nigra neurons: stability and energy analysis.

Authors:  Febe Francis; Míriam R García; Richard H Middleton
Journal:  J Comput Neurosci       Date:  2013-05-19       Impact factor: 1.621

3.  An energy systems approach to Parkinson's disease.

Authors:  Peter Wellstead; Mathieu Cloutier
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2011 Jan-Feb

4.  Dynamic modelling of protein and oxidative metabolisms simulates the pathogenesis of Parkinson's disease.

Authors:  M Cloutier; P Wellstead
Journal:  IET Syst Biol       Date:  2012-06       Impact factor: 1.615

5.  Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons.

Authors:  Consiglia Pacelli; Nicolas Giguère; Marie-Josée Bourque; Martin Lévesque; Ruth S Slack; Louis-Éric Trudeau
Journal:  Curr Biol       Date:  2015-08-27       Impact factor: 10.834

Review 6.  Premotor and nonmotor features of Parkinson's disease.

Authors:  Jennifer G Goldman; Ron Postuma
Journal:  Curr Opin Neurol       Date:  2014-08       Impact factor: 5.710

7.  A Computational Model of Loss of Dopaminergic Cells in Parkinson's Disease Due to Glutamate-Induced Excitotoxicity.

Authors:  Vignayanandam Ravindernath Muddapu; Alekhya Mandali; V Srinivasa Chakravarthy; Srikanth Ramaswamy
Journal:  Front Neural Circuits       Date:  2019-02-25       Impact factor: 3.492

8.  Integrated dopaminergic neuronal model with reduced intracellular processes and inhibitory autoreceptors.

Authors:  Maell Cullen; KongFatt Wong-Lin
Journal:  IET Syst Biol       Date:  2015-12       Impact factor: 1.615

9.  Living on the edge with too many mouths to feed: why dopamine neurons die.

Authors:  J Paul Bolam; Eleftheria K Pissadaki
Journal:  Mov Disord       Date:  2012-09-24       Impact factor: 10.338

View more
  8 in total

1.  Cognitive Performance is Associated with Altered Cerebral Hemodynamics Assessed by Transcranial Ultrasound in Parkinson's Disease.

Authors:  Yi-Lun Ge; Si-Yi Gong; Pu-Zhi Wang; Jia-Hui Yan; Wen Li; Jin-Ru Zhang; Hong Jin; Sheng Zhuang; Lei Hu; Chang-Wei Ding; Ya-Ping Yang; Fen Wang; Dan Li; Jing Chen; Cheng-Jie Mao; Ying-Chun Zhang; Kai Li; Chun-Feng Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2022-07-12       Impact factor: 2.989

Review 2.  The role of NURR1 in metabolic abnormalities of Parkinson's disease.

Authors:  Murad Al-Nusaif; Yuting Yang; Song Li; Cheng Cheng; Weidong Le
Journal:  Mol Neurodegener       Date:  2022-06-27       Impact factor: 18.879

Review 3.  Alpha-Synuclein Aggregation Pathway in Parkinson's Disease: Current Status and Novel Therapeutic Approaches.

Authors:  Marija Vidović; Milena G Rikalovic
Journal:  Cells       Date:  2022-05-24       Impact factor: 7.666

4.  DOPA Homeostasis by Dopamine: A Control-Theoretic View.

Authors:  Rune Kleppe; Qaiser Waheed; Peter Ruoff
Journal:  Int J Mol Sci       Date:  2021-11-28       Impact factor: 5.923

Review 5.  Insights into the Pathogenesis of Neurodegenerative Diseases: Focus on Mitochondrial Dysfunction and Oxidative Stress.

Authors:  Anamaria Jurcau
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923

6.  A Multi-Scale Computational Model of Levodopa-Induced Toxicity in Parkinson's Disease.

Authors:  Vignayanandam Ravindernath-Jayashree Muddapu; Karthik Vijayakumar; Keerthiga Ramakrishnan; V Srinivasa Chakravarthy
Journal:  Front Neurosci       Date:  2022-04-19       Impact factor: 5.152

7.  Hypoxia and Alpha-Synuclein: Inextricable Link Underlying the Pathologic Progression of Parkinson's Disease.

Authors:  Mengyuan Guo; Xunming Ji; Jia Liu
Journal:  Front Aging Neurosci       Date:  2022-07-26       Impact factor: 5.702

8.  A Multiscale, Systems-Level, Neuropharmacological Model of Cortico-Basal Ganglia System for Arm Reaching Under Normal, Parkinsonian, and Levodopa Medication Conditions.

Authors:  Sandeep Sathyanandan Nair; Vignayanandam Ravindernath Muddapu; V Srinivasa Chakravarthy
Journal:  Front Comput Neurosci       Date:  2022-01-03       Impact factor: 2.380

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.